UOC
IRON icon

UBS O'Connor’s Disc Medicine IRON Stock Holding History

UBS O'Connor’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,317
Closed -$652K – 369
2025
Q2 		$652K Sell
12,317
-1,304
-10% -$61.3K 0.02% 258
2025
Q1 		$676K Sell
13,621
-636
-4% -$35.4K 0.02% 210
2024
Q4 		$904K Sell
14,257
-426
-3% -$24.6K 0.02% 238
2024
Q3 		$722K Buy
14,683
+1,364
+10% +$64K 0.02% 311
2024
Q2 		$600K Buy
13,319
+10,000
+301% +$340K 0.02% 355
2024
Q1 		$207K Sell
3,319
-6,019
-64% -$390K 0.01% 400
2023
Q4 		$539K Sell
9,338
-13,783
-60% -$706K 0.02% 342
2023
Q3 		$1.09M Buy
23,121
+6,000
+35% +$300K 0.02% 324
2023
Q2 		$760K Sell
17,121
-28,629
-63% -$1.02M 0.02% 408
2023
Q1 		$969K Buy
+45,750
New +$1.02M 0.02% 407

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return